India Intravenous Anesthetic Market Analysis (2019-2027)

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. INDIA INTRAVENOUS ANESTHETIC MARKET ANALYSIS (2019-2027) India Intravenous Anesthetic Market, by Type (Barbiturates, Ketamine, Benzodiazepines, Propofol, and Others) and by End User (Hospitals, Clinics, and Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

3. India Intravenous Anesthetic Market– Insights • India is one of the highest populated countries in the world. The increasing geriatric population, changing lifestyle, and rising number of chronic diseases are expected to drive demand for intravenous anesthetics. For instance, according to the OECD (Organization for Economic Co-operation and Development), in India, around 10,000 heart bypass, 8,500 knee replacement, and 5,500 spinal fusion surgeries were performed in 2011. The surgical treatment cost advantage compared to other countries is a major factor that increases the number of surgeries conducted in India, which is expected to drive growth of the market over the forecast period.  • In addition, increasing government expenditure on healthcare sector is another factor that is expected to drive growth of the global intravenous anesthetic market. For instance, during 2016-2017, India Government spent around 1.02% of the total GDP (gross domestic product) and it increased to around 1.28% in the period 2017-2018. The increasing government spending on public health is to support each individual to gain needful treatment. It also helps to reduce treatment cost burden and provide treatment access to patient with chronic disease problems. • The India intravenous anesthetic market is estimated to be valued at US$ 65.0 million in 2019 and is expected to exhibit a CAGR of 2.6% over the forecast period (2020-2027).

4. India Intravenous Anesthetic Market Share (%) Analysis, By Type, 2019

5. Furthermore, increasing government support for public healthcare is a key driving factor that is expected to drive growth of the India intravenous anesthetic market. For instance, in 2018, the Government of India launched nationwide health care reform ‘Ayushman Bharat’. This scheme of Indian government had taken significant step towards universal health coverage. Under this scheme, poor and vulnerable families receives financial coverage for hospital expenses for secondary and tertiary care.

6. India Intravenous Anesthetic Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027

7. India Intravenous Anesthetic Market- Competitive Landscape • Major players operating in the India intravenous anesthetic market include AstraZeneca Plc, Fresenius Kabi, AbbVie Inc., Baxter International Inc., B. Braun Melsungen AG, Maruishi Pharmaceutical Co., Ltd, Piramal Healthcare, Hikma Pharmaceuticals, and Mylan N.V.

8. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/india-intravenous-anesthetic-market-3558

9. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

10. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

11. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/